Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene

Atherosclerosis

Volumn 150, Issue 1, 2000, Pages 135-141

  Sentí, Mariano ^a   Bosch, Mireia ^a   Aubó, Clara ^a   Elosua, Roberto ^a   Masià, Rafel ^b   Marrugat, Jaume ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Abdominal obesity; Genetics; Lipoprotein lipase; Protective lipid profile

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD; BODY CONSTITUTION; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERLIPIDEMIA; MIDDLE AGED; MUTATION; OBESITY; PATHOLOGY; RISK FACTOR;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BODY CONSTITUTION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MIDDLE AGED; MUTATION; OBESITY; POLYMORPHISM, GENETIC; RISK FACTORS; TRIGLYCERIDES;

EID: 0034183324     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00355-X     Document Type: Article

References (31)

1. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-62.
2. Freedman DS, Jacobsen SJ, Barboriak JJ, et al. Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 1990;81:1498-506.
3. Cassassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality: The Paris Prospective Study. Arterioscler Thromb 1992;12:1387-92.
4. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-86.
5. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:88-98.
6. Nielsen S, Jensen MD. Obesity and cardiovascular disease: is body structure a factor? Curr Opin Lipidol 1997;8:200-4.
7. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996;45:1119-24.
8. Després JP, Verdon MF, Moorjani S, et al. Apolipoprotein E polymorphism modifies relation of hyperinsulinemia to hypertriglyceridemia. Diabetes 1993;42:1474-81.
9. Pouliot MC, Després JP, Dionne FT, et al. ApoB-100 gene EcoRI polymorphism associated with abdominal visceral obesity. Arterioscler Thromb 1994;14:527-33.
10. Uusitupa MIJ, Karthunen L, Rissanen A, et al. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women. Am J Clin Nutr 1996;64:131-6.
11. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Molecular Basis of Inherited Disease. New York: McGraw-Hill, 1989:1165-80.
12. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989;79:85-91.
13. Heizmann C, Kirchgessner T, Kwiterowich PO, et al. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet 1991;86:578-84.
14. Vohl M-C, Lamarche B, Moorjani S, et al. The lipoprotein HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol 1995;15:714-20.
15. Masiá R, Pena A, Marrugat J, et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. J Epidemiol Community Health 1998;52:707-15.
16. Pérez G, Pena A, Sala J, Roset P, Masiá R, Marrugat J. Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in the province of Girona, Spain, 1990 to 1992. Int J Epidemiol 1998;27:599-604.
17. Taylor HL, Jacobs Dr Jr, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978;31:741-7455.
18. Elosua R, Marrugat J, Molina L, Pons S, Pujol E. Validation of the Minnesota leisure time physical activity questionnaire in Spanish men. Am J Epidemiol 1994;139:1197-209.
19. Garcia M, Elosua R, Aguilar A, Ruiz MA, Covas MI, Marrugat J. Validation of the Minnesota leisure time physical activity questionnaire in Spanish women. Rev Esp Cardiol 1998;51 (Suppl. 5):132.
20. Havel RJ. Role of triglyceride-rich lipoproteins in progression of atherosclerosis. Circulation 1990;81:694-6.
21. Senti M, Nogués X, Pedro-Botet J, Rubiés-Prat J, Vidal-Barraquer F. Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes. Circulation 1992;85:30-6.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1989;16:1215.
23. Hata A, Robertson M, Emi M, Lalouel J-M. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nosense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acid Res 1990;18:5407-11.
24. Mattu RK, Needham EWA, Morgan R, et al. DNA variants at the LPL gene locus associate with angiographically denned severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994;14:1090-7.
25. Kissebah AH. Intra-abdominal fat: is it a major factor in developing diabetes and coronary artery disease? Diabetes Res Clin Pract 1996;30(Suppl.):25-30.
26. Groenemeier BE, Hallaman MD, Reymer PW, et al. Genetic variant showing a positive interaction with β-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 1997;95: 2628-35.
27. Enerbäck S, Ohlsson BG, Samuelsson L, Bjursell G. Characterisation of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-α and LP-β, of importance for the differentiation-linked induction of the LPL gene during adipogenesis. Mol Cell Biol 1992;12:4622-33.
28. Fox AA, Thompson JL, Butterfield GE, Gylfadottir U, Moynihan S, Spiller G. Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women. Am J Clin Nutr 1996;63:225-33.
29. Lehmann R, Vokac A, Niedermann K, Agosti K, Spinas GA. Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. Diabetologia 1995;38:1313-9.
30. Hwang SJ, Beaty TH, Liang KY, et al. Minimum sample size estimation to detect gene-environment interaction in case-control designs. Am J Epidemiol 1994;140:1029-37.
31. Ushiroyama T, Okamoto Y, Sugimoto O. Plasma lipid and lipoprotein levels in perimenopausal women. Acta Obstet Gynecol Scand 1993;72:428-33.